[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Orlistat OTC (marketed as alli) Information

The Food and Drug Administration approved the drug product orlistat 60 mg capsule (trade name alli) on February 7, 2007, for over-the-counter marketing as a weight loss aid. Alli is to be used only in conjunction with a weight loss program that includes a reduced calorie diet, a low fat diet, and an exercise program. It is approved for use in adults 18 years and older. A multivitamin should be taken every day when alli is used as part of a weight loss program.

to top arrow Back to Top     back arrow Back to Drug Information

PDF document PDF requires the free Adobe Acrobat Reader

Date created: February 12, 2007

horizonal rule